About Fernway
Fernway is a company based in Northampton (United States) founded in 2018 by David Van Vlierbergen, Christopher Gallant, and Liam O'Brien. Fernway has raised $3.09 million across 4 funding rounds. The company has 45 employees as of December 31, 2022. Fernway offers products and services including Vapes, Joints, Stylus, and Apparel. Fernway operates in a competitive market with competitors including Syqe, Kanabo, Dosist, Philter and Resolve Digital Health, among others.
- Headquarter Northampton, United States
- Employees 45 as on 31 Dec, 2022
- Founders David Van Vlierbergen, Christopher Gallant, Liam O'Brien
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.09 M (USD)
in 4 rounds
-
Latest Funding Round
$4.83 M (USD), Debt – Conventional
Aug 09, 2023
-
Investors
Not available
-
Employee Count
45
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fernway
Fernway offers a comprehensive portfolio of products and services, including Vapes, Joints, Stylus, and Apparel.
High-quality cannabis vapes for adult consumption
Terpene-infused joints for smoking purposes
Vape device designed for cannabis use
Clothing items related to cannabis culture
People of Fernway
Unlock access to complete
Funding Insights of Fernway
Fernway has successfully raised a total of $3.09M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.83 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Fernway
Investment portfolio details for Fernway
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fernway
Detailed financials for Fernway
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fernway Comparisons
Peer comparison for Fernway
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fernway
Fernway operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syqe, Kanabo, Dosist, Philter and Resolve Digital Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precise dosing inhaler for medical cannabis is developed.
|
|
| Locked | Locked | Locked |
Cannabis-based medical and consumer products are developed by Kanabo.
|
|
| Locked | Locked | Locked |
Cannabis strains are sourced and processed for therapeutic products.
|
|
| Locked | Locked | Locked |
Vapour cigarettes are branded and offered by Philter.
|
|
| Locked | Locked | Locked |
Smart inhalers and health monitoring devices are developed for wellness.
|
Detailed competitors of Fernway
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fernway
Complete news archive for Fernway
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fernway
Fernway was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Fernway is headquartered in Northampton, United States. It is registered at Northampton, Massachusetts, United States.
Christopher Gallant is the current CEO of Fernway. They have also founded this company.
Fernway is a funded company, having raised a total of $3.09M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Fernway is 45.
Fernway was founded in 2018 and is headquartered in Northampton, United States. Cannabis-based vaping products are offered by the company, focusing on vaporizer cartridges formulated with cannabis oil and natural terpenes. Various flavors, including grapefruit, homegrown, stone fruits, Berkshire gold, berry haze, and wild mint, are available. Operations center on the production and distribution of these cartridges within the cannabis sector.
Fernway offers Vapes, Joints, Stylus, and Apparel.